Status:

UNKNOWN

Diesel Exhaust and Vascular Function

Lead Sponsor:

University of Washington

Collaborating Sponsors:

National Institute of Environmental Health Sciences (NIEHS)

Environmental Protection Agency (EPA)

Conditions:

Cardiovascular Effects

Eligibility:

All Genders

18-49 years

Phase:

NA

Brief Summary

Double-blind, sham- and placebo-controlled randomized study of effects of freshly-generated diluted diesel exhaust inhalation on vascular function. To examine role of adrenergic system a trial of alph...

Eligibility Criteria

Inclusion

  • healthy without chronic illness
  • Body Mass Index 18.5 - 26.0
  • tolerates 2 mg terazosin dose without unacceptable symptoms
  • able to return for four exposure sessions

Exclusion

  • any chronic disease
  • tobacco user
  • asthma
  • elevated cholesterol
  • obesity
  • hypertension
  • diabetes
  • any chronic cardiovascular or pulmonary disease
  • pregnancy or unwillingness to use effective contraception, if female

Key Trial Info

Start Date :

January 1 2012

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 1 2015

Estimated Enrollment :

24 Patients enrolled

Trial Details

Trial ID

NCT01508637

Start Date

January 1 2012

End Date

December 1 2015

Last Update

August 3 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Washington Medical Center

Seattle, Washington, United States, 98195

Diesel Exhaust and Vascular Function | DecenTrialz